(P048) Quality Assurance Assessment of Diagnostic and Therapy Simulation Computed Tomography Image Registration for Head and Neck Radiotherapy: Anatomic Region of Interest–Based Comparison of Rigid and Deformable Algorithms

Publication
Article
OncologyOncology Vol 28 No 1S
Volume 28
Issue 1S

The purpose of this study was to develop a workflow process that enables quantitative assessment of different image registration techniques used for head and neck simulation CT to diagnostic CT coregistration.

Abdallah S. Mohamed, MD, MSc, Manee-Naad Ruangskul, MD, Musaddiq J. Awan, MD, Charles A. Baron, MD, Richard Castillo, PhD, Edward Castillo, PhD, Thomas M. Guerrero, MD, PhD, Esengul Kocak-Uzel, MD, Jinzhong Yang, PhD, Laurence Court, PhD, G. Brandon Gunn, MD, Adam S. Garden, MD, David I. Rosenthal, MD, Clifton D. Fuller, MD, PhD; UT MD Anderson Cancer Center

Background and Purpose: Developing a framework to validate the performance of image registration algorithms is critical before application for tumor localization and therapeutic targeting. The purpose of this study was to develop a workflow process that enables quantitative assessment of different image registration techniques used for head and neck simulation CT (SimCT) to diagnostic CT (DxCT) coregistration.

Materials and Methods: A total of 68 reference anatomic regions of interest (ROIs) were manually contoured on each of 11 paired SimCTs and DxCTs of head and neck patients treated with definitive intensity-modulated radiotherapy (IMRT). DxCT was registered to SimCT rigidly and through four different deformable image registration (DIR) algorithms: Atlas-based, b-spline, demons, and optical flow. The resultant deformed ROIs were compared with manually contoured reference ROIs using similarity coefficient metrics (ie, Dice similarity coefficient) and surface distance metrics (ie, 95% maximum Hausdorff distance).

Results: All DIR algorithms showed improved performance over rigid registration for all used comparison metrics (Steel test: P < .008 after Bonferroni correction), excepting optical flow for surface distance metrics. The Atlas-based algorithm had the best DIR performance (mean Dice of 0.65 ± 0.15, mean false-negative Dice of 0.11 ± 0.18, mean false-positive Dice of 0.58 ± 0.26, and mean 95% maximum Hausdorff distance of 6.79 mm ± 7.6). The performance of different algorithms varied substantially for specific anatomic ROIs and subgroups. Overall, the performance of most algorithms was better in matching bony and cartilaginous ROIs than muscular, glandular, vascular, and other soft tissue ROIs.

Conclusions: Development of a formal ROI-based quality assurance workflow for registration assessment revealed improved performance with DIR techniques over rigid fusion and provided head and neck ROI-specific benchmarks for DxCT-SimCT coregistration for future efforts. After QA, DIR implementation should be the standard for head and neck DxCT-SimCT allineation.

Articles in this issue

(P113) Age and Marital Status Are Associated With Choice of Mastectomy in Patients Eligible for Breast Conservation Therapy
(P112) Single-Institution Experience With Intrabeam IORT for Treatment of Early-Stage Breast Cancer
(P110) Breast Cancer Before Age 40: Current Patterns in Clinical Presentation and Local Management
(P111) Accelerated Partial-Breast Irradiation With Multicatheter High-Dose-Rate Brachytherapy: Feasibility and Results in a Private Practice Cohort
(P115) Breast Cancer Laterality Does Not Influence Overall Survival in a Large Modern Cohort: Implications for Radiation-Related Cardiac Mortality
(P117) Anatomical Variations and Radiation Technique for Breast Cancer
(P116) Bilateral Immediate DIEP Reconstruction and Postmastectomy Radiotherapy: Experience at a Tertiary Care Institution
(P118) Metadherin Overexpression Is Associated With Improved Locoregional Control After Mastectomy
(P119) Effect of Economic Environment on Use of Postlumpectomy Radiation Therapy for Stage I Breast Cancer
(P120) Immediate Versus Delayed Reconstruction After Mastectomy in the United States Medicare Breast Cancer Patient
(P121) Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004–2009
(P122) Streamlining Referring Physicians Orders With ‘Reflex Testing’ Significantly Decreases Time to Resolution for Abnormal Screening Mammograms
(P123) National Trends in the Local Management of Early-Stage Paget Disease of the Breast
(P124) Effect of Inhomogeneity on Cardiac and Lung Dose in Partial-Breast Irradiation Using HDR Brachytherapy
(P125) Breast Cancer Outcomes With Anthracycline-Based Chemotherapy for Residual Disease Burden After Full-Dose Neoadjuvant Chemotherapy and Surgery Followed by Radiation Treatment
Recent Videos
Once a patient-specific dose is determined, an all-oral combination of revumenib plus decitabine/cedazuridine and venetoclax may be “very good” in AML.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 67th Annual ASH Meeting in Orlando.
Patients with mediastinal lymph node involved-lung cancer may benefit from chemoimmunotherapy in the neoadjuvant setting.
Stressing the importance of prompt AE disclosure before they become severe can ensure that a patient can still undergo resection with curative intent.
Thomas Marron, MD, PhD, presented a session on clinical data that established standards of care for stage II and III lung cancer treatment at CFS 2025.
Sonia Jain, PhD, stated that depatuxizumab mafodotin, ABBV-221, and ABBV-321 were 3 of the most prominent ADCs in EGFR-amplified glioblastoma.
Skin toxicities are common with targeted therapies for GI malignancies but can be remedied by preventative measures and a collaboration with dermatology.
Computational models help researchers anticipate how ADCs may behave in later lines of development, while they are still in the early stages.
ADC payloads with high levels of potency can sometimes lead to higher levels of toxicity, which can eliminate the therapeutic window for patients with cancer.
Related Content